Method AI has raised $20 million to develop its 3D ultrasound and AI-based surgical guidance technology.
Key Details
- 1Method AI raised $20 million in Series A financing led by a private family office.
- 2The company is a 2021 spinoff from the Cleveland Clinic.
- 3Its platform uses continuous 3D ultrasound and AI-generated plans for robotic-assisted surgery.
- 4Funding will support further product development; FDA clearance has not yet been obtained.
Why It Matters
This funding highlights growing investment in AI-powered imaging guidance for surgery—an area with potential to improve precision and outcomes. The use of continuous 3D ultrasound combined with AI represents a promising advance for radiology-integrated surgical platforms.
Source
Radiology Business
Related News
•Cardiovascular Business
FDA Clears AI Platform for Comprehensive Cardiac Risk Assessment on CT
HeartLung Corporation's AI-CVD receives FDA clearance for opportunistic multi-condition screening on routine chest CT scans.
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.
•Cardiovascular Business
FDA Expands Clearance for AI-Guided Echo Exams on Existing Ultrasound Systems
FDA clears UltraSight's AI platform for use with a broader range of existing ultrasound devices, aiding novice users in performing echocardiographic exams.